These tests create a baseline for your pregnancy. They show your starting haemoglobin, blood group, infection status, sugar control, and thyroid function so your OB is not guessing later if symptoms appear.

They also screen for common risks in India, especially anaemia, diabetes, urinary infection, hepatitis, and Rh incompatibility. Catching these early reduces preventable complications for both mother and baby.

The ideal timing is the first prenatal visit, preferably before 12 weeks. Early results help personalise supplements, follow-up frequency, vaccines, scans, and referral plans if a problem is already present.

CBC checks haemoglobin, white blood cells, and platelets. In pregnancy, haemoglobin is especially important because anaemia remains very common in India and can worsen fatigue, dizziness, preterm birth risk, and recovery after delivery.

A haemoglobin below 11 g/dL in pregnancy usually needs treatment, often with iron and folate, plus diet advice and repeat testing. If iron deficiency is suspected, your doctor may add ferritin to confirm depleted iron stores.

Platelets help blood clot normally, so low counts matter for delivery planning. White blood cells can rise mildly in pregnancy, but a clear increase with symptoms may point to infection and needs clinical context.

This test identifies your ABO blood group as A, B, AB, or O, and whether you are Rh positive or Rh negative. ABO type matters for transfusion safety. Rh type matters for future fetal blood compatibility.

If the mother is Rh negative, the pregnancy needs special attention. Anti-D injection is usually given at about 28 weeks and again after delivery if the baby is Rh positive, helping prevent Rh disease in this or later pregnancies.

Your partner's blood group can help estimate the chance of Rh mismatch, though the mother's result drives pregnancy planning. For a fuller explanation, see Rh-Negative Pregnancy in India: Why Anti-D Immunoglobulin, the Indirect Coombs Test and the 72-Hour Rule Matter for Every Rh-Negative Mother.

TORCH refers to infections such as Toxoplasma, Rubella, Cytomegalovirus, and Herpes, with some clinics also discussing other infection screens alongside it. It is mainly used to look for immunity, recent infection, or a reason to investigate further.

Rubella status is particularly useful. Rubella IgG suggests past immunity, while a recent infection pattern needs careful interpretation by your doctor because timing in early pregnancy matters.

TORCH is not always ordered for every pregnancy in the same way across India. It is more often considered in the first trimester, in women with suggestive symptoms, or when past pregnancy history raises concern.

These infection screens are central to first-visit care in India. HIV testing is part of NACO-linked antenatal screening and is free, confidential, and important because timely treatment greatly lowers mother-to-child transmission.

VDRL screens for syphilis, HBsAg screens for Hepatitis B, and HCV screens for Hepatitis C. All matter because some infections can affect pregnancy, delivery planning, newborn care, or partner testing.

A positive result does not mean the pregnancy is lost. These conditions are treatable or manageable, and early detection is exactly what improves outcomes for both mother and baby.

Your doctor may order fasting and post-meal sugar values, or sometimes HbA1c, to identify pre-existing diabetes or early abnormal glucose control. This is different from waiting for routine later-pregnancy screening alone.

Women with PCOS, BMI above 25, family history of diabetes, or a previous pregnancy with gestational diabetes are higher risk. In these cases, an OGTT may be advised even at the first visit.

Early detection changes food advice, follow-up timing, and medication decisions. For the India-specific diabetes pathway, see Gestational Diabetes in India: OGTT Screening, Indian Diet Plan and Safe Management.

Indian guidance often supports universal thyroid screening in pregnancy because thyroid problems are common and frequently silent. TSH is the main first test, and free T4 may be added depending on the result.

In the first trimester, many OBs aim for TSH below 2.5. If hypothyroidism is found, treatment with levothyroxine may need to start immediately or the pre-pregnancy dose may need adjustment.

This matters because untreated thyroid dysfunction can affect maternal wellbeing and pregnancy outcomes. Women already on thyroid medicine should not wait for symptoms before rechecking levels.

Vitamin D deficiency is very common in Indian women, and B12 deficiency is more likely in women eating little or no animal food. Folate status also matters because folate is essential in early fetal development.

These tests are not identical in every clinic, but they may be added when diet history, prior deficiency, fatigue, neuropathy, or bone pain raises suspicion. Results help your OB choose targeted supplements instead of guessing.

Do not start high-dose supplements on your own just because a friend was prescribed them. The right dose depends on your report, symptoms, and what you are already taking in your prenatal tablet.

Urine testing often accompanies first-visit blood work because it gives different but equally useful information. Protein can suggest kidney issues or later preeclampsia risk, sugar can support diabetes evaluation, and pus cells may suggest infection.

UTI can be common in pregnancy and may sometimes cause few symptoms. When symptoms or report findings suggest infection, a urine culture helps confirm the organism and guide the right antibiotic.

Treating UTI early matters because untreated infection can travel upward, worsen maternal illness, and increase the risk of preterm complications. That is why urine testing remains a routine part of early antenatal care.

Government facilities such as PHCs and public hospitals often provide core antenatal tests free under schemes like PMSMA and JSSK. In many areas, ASHA workers help women reach the PHC, and Ayushman Bharat may support eligible care pathways.

In private hospitals such as Apollo, Cloudnine, or Cocoon, a first-visit package often falls around Rs 2000 to Rs 6000 depending on city and test mix. Standalone lab packages with home collection from chains like Dr Lal PathLabs, Metropolis, or SRL may be around Rs 1500 to Rs 4500.

TORCH alone may cost roughly Rs 2000 to Rs 4000, while HIV, VDRL, HBsAg, and HCV bundled together may be around Rs 500 to Rs 1500. Prices vary by city, fasting requirements, and whether doctor consultation is bundled.